SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic. (8th March 2022)
- Record Type:
- Journal Article
- Title:
- SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic. (8th March 2022)
- Main Title:
- SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic
- Authors:
- Mohapatra, Ranjan K.
Kuppili, Satwik
Kumar Suvvari, Tarun
Kandi, Venkataramana
Behera, Ajit
Verma, Sarika
Kudrat‐E‐Zahan,
Biswal, Susanta K.
Al‐Noor, Taghreed H.
El‐ajaily, Marei M.
Sarangi, Ashish K.
Dhama, Kuldeep - Abstract:
- Abstract: The ongoing COVID‐19 pandemic caused by SARS‐CoV‐2 is associated with high morbidity and mortality. This zoonotic virus has emerged in Wuhan of China in December 2019 from bats and pangolins probably and continuing the human‐to‐human transmission globally since last two years. As there is no efficient approved treatment, a number of vaccines were developed at an unprecedented speed to counter the pandemic. Moreover, vaccine hesitancy is observed that may be another possible reason for this never ending pandemic. In the meantime, several variants and mutations were identified and causing multiple waves globally. Now the safety and efficacy of these vaccines are debatable and recommended to determine whether vaccines are able to interrupt transmission of SARS‐CoV‐2 variant of concern (VOC). Moreover, the VOCs continue to emerge that appear more transmissible and less sensitive to virus‐specific immune responses. In this overview, we have highlighted various drugs and vaccines used to counter this pandemic along with their reported side effects. Moreover, the preliminary data for the novel VOC "Omicron" are discussed with the existing animal models. Abstract : This overview highlighted various drugs and vaccines used to counter this pandemic along with their reported side effects. Moreover, the preliminary data for the novel VoC "Omicron" are discussed with the existing animal models.
- Is Part Of:
- Chemical biology & drug design. Volume 99:Number 5(2022)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 99:Number 5(2022)
- Issue Display:
- Volume 99, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 99
- Issue:
- 5
- Issue Sort Value:
- 2022-0099-0005-0000
- Page Start:
- 769
- Page End:
- 788
- Publication Date:
- 2022-03-08
- Subjects:
- animal models -- drugs and vaccines -- SARS‐CoV‐2 VOCs -- vaccine effectiveness -- vaccine hesitancy -- vaccine side effects
Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.14035 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21287.xml